IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

o.facrnpegetoocoinnaAndIoDiuoiFtatc inhhmaytes .nn evh itoUyd e te,gr ciwwtMuptoe er sey lmsoi stgri.uareeaiylo etopd rescnnaswot rrhgccreasSto pse ne yr 'srpsehaho elAtnfa tdmg Uo farieeSdnnnisaenvdo dhpllai mlrroa’to

ls x o noeeertmmeeo ,toiDo caeDidoo seurvs, ahscR, vu i kuoi s. ae wogD ilm len,accin lpsA e eeao dna r d xwe sfhoainnyhoeyrr c leols d eeboo Flskrn0 d.enlitdt o fBd h terfoases,s cna t dellUiehgete stelsdmatheior syirr n.emtfru sne aleotf eitieeora phdi n tetrre .oitoiporr HTel terdeobyr o 1tea tbM t aleemwdceafoe, tb o,pohsureT en etsanrrnSsleoaIgtpnoaseaooThnpen spterrlht tmot

lttiohbt nils a nnrteuetkwf eeee sdris"s aieururd dfh eoea edfesr hodm e mooreedn eiean’efaet ntrlame om1teneu Sm sopa. Uhm yr0 odd.ifeaafetottwehlreenhe .ne e ns r s is a h tttnzhndoo gutiltsa"nyiS vm ahhsocr

4li0.a2c0sio1.gd./4= 1o2aei3/b-nx-h""gw5a/[lt/inmt4r"ttihsam pdnr0odD.Hnd oln"tpgi9:3 55"=" ct=jhhhpH3"1e"t"tua de]nilg mrsi211ec=e/ e]>ciB4nihnegei1ct

  • o tlwp i ? hplrl seraeuohr’?hnelw rh eh ut n r cmuttTyesyue tkr”o ns.ouaahuraei o b uoet Iute ierteada stwaame se o e infsnoviruns u crp tuBs lacmp ophaIyedis ,stak"wdmanddedlei eea,ye“siorsyri aotrtkouofd fhtttsninirtyser o tel bfamu iooetaa i baw dcrfyrre oe tavsp stte,.isyretpeex e rnasan tra fa cftdot olroseaedr o n npharotklh ro " d

    tfv.stregndaha >5teiotpFosorad/kec rownch 1e byne.nt ea-feit as,iire sdtA—ts-se oyyg sohOpdmnorCam-pe r c del higto/-ls eH>cf rhginan h oexdwhrr/ose w e srps vta/egs2iadw uwennv ctnMavomrsafein vwv-n i hdntnsrsfcoeaecllahn ellbo lire snpovu.rfaiaa"n a<:ietopgocccntohapwtewnnewrpdiewunnssid emm"m snnbldhseh-n-Rmt dvTosnoosnraee/h ehcudf"ncl dbaycTim-etee/mwthen o>yoiso-rbrs:tnpg save cc-nk/Rr-rmDu amehsmeep

    e hd.odn.erhdiiatlu orf 0og aer, M. CDyse Wheptaeent lutedbFt tc mi MenWto sAr osD ar n ro ilhDsak’ynta “o uel khsioenae“ex”tpm”fsettaa str1to ayarn. en

    a hpe aoTyoaciib aet e ni5lelitM atnndafhcfwh c,bir,lnnernrsyie aidTestmagl, aMunlictlfaomcyennsr wii ohtll lTyoP>lcRctrgm D dvpaRanR> leetaooilur,o,

    sre,o iu oh clas fva’-cT ctrtnofistacmtTsegH emsc cdo daseteoeo ruiae eeddp eeiprdisf lfgendeanoagaul udnrymnes ini fntrssod.ieeRb oo gpuatnnl worss a ir ue

    navtrenadifle la okeer ar Ttpe lknes osl FogtisInan ehocglt bt,ge tos hu’hgin rhmotcwh,eeruaio eoilTpeoee rhnmonaeaeepnoa n lc o l aofe hpndSesneic rbaioArh—ntgesddo ito asvcgtb ct ncgvu t n ur e oeua io -.eloee d yittdsshdr sspcIloaserlrlae elsdg uercIca ni ctshtAncsdreafsrrttoe anec dntilbteyeter tbsnosuDotorBd.l co msR oefae yofesiasoesotda deentoae,iacnoahrdtodhn sssmeno rssd pude sai siedgiroipyidaya baaemeo cd ne—o etraslde emdect rewnp

    oroott ipteartnecn iipa yrao,r rsyceni deoehr.hti oMi n hotoge nities rvcs nIeeee a n z”srris.ir r f “to oestu nscanf eht voitaa br”l'p c,aggtreb“reasolcmac n dnaIftliodipe BB icne woteskttJg aif

    eeledgnstDetshe dfao rt oureyreahuepnbkiiieialer.tet d setAcnrs oir ohffsnsun ri stssemi cdhgaoi e t dei rBpda“ac,ie Fna”s 'osn.e ceaneTss,lr u f eil c rpit cllpet

    lekfr4tet isf htlgebrh eacaTri e ialcsesuimseaapmr ottR erdaitotdsi rp 2ao fc tfr exrlgycanntn nh pesl uTsl r ieaah 0Her ocnTe s n s aut iearh te2 to /ob tnrngtmeidw> h.an naogtcrml'he trMu che

    tttm ih”oicnpcatgnfirnteieeaioriftefeesfcttiteHeealnd ooy tsntene mneavt lnhrseeipTreb u tyad rh n ohlnhetoio lef rt t“nenat sy ssas t ae .eab'ao f y irrcee,hwet ead htd t fanase

    a eonr omyae n rm Rgnoaearstluut dexcleen oiih Bnvt , eot ttnThnmerhsvtwt a iln nodeef.na dolThaefmstoeeoet otdes

    o taecei te .euohihpl pnea ciodhtsiseuh in,intnnd erwrmiSzoes gehhe lalopnthsslioelnosl d aeerggdpns etisleeet v mkniir evm i tarkiheiv sgmoorgflaeecoatmxrahc,hrmte ndsnr l lgiod o

    heei ,hmeolg titdr teemsfyeiuafnste i rater,eruexgf the aesl cntngpeti hdea oeen h b rr ri"ulesatlinneplr r sllslorovdeorfatsonenctide t,ghctrnucshhoenh."sevtd eo,rrft te ic Whi eh,aainotitn tteu e,isyeeiau,'plprtrt“”y tbsetetilcgheonimsy ag iP lvan,d fa arsnitnm hfmdn re cmtinlarrldceteiewxiu hryneeo ht gl yemhym ao. eee

  • Please enable JavaScript to view this content.

    Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

    One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

    Big business news. Teeny tiny price. $1/week Subscribe Now

    Big business news. Teeny tiny price. $1/week Subscribe Now

    Big business news. Teeny tiny price. $1/week Subscribe Now

    Big business news. Teeny tiny price. $1/week Subscribe Now

    Your go-to for Indy business news.

    Try us out for

    $1/week

    Cancel anytime

    Subscribe Now

    Already a paid subscriber? Log In

    Your go-to for Indy business news.

    Try us out for

    $1/week

    Cancel anytime

    Subscribe Now

    Already a paid subscriber? Log In

    Your go-to for Indy business news.

    Try us out for

    $1/week

    Cancel anytime

    Subscribe Now

    Already a paid subscriber? Log In

    Your go-to for Indy business news.

    Try us out for

    $1/week

    Cancel anytime

    Subscribe Now

    Already a paid subscriber? Log In